Menu
Recruiting NCT07137468

Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk

Observational Breast Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Surveys, Video.
Who it may be relevant to
Registry conditions: Breast Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Excessive Weight, Breast Cancer, and Endocrine Disrupting Chemicals (EDCs): Findings From Active Living After Cancer (ALAC) With Environmental Vitality

Overview

To learn about breast cancer survivors' and their family members' knowledge of and interest in learning about environmental exposures related to personal care products. Researchers also want to learn if there is a link between excessive weight and chemicals that may affect hormones.

Detailed description

Primary Objectives:

Excessive body weight and endocrine disrupting chemicals (EDCs) are interconnected risk factors for breast cancer through disruptions in hormone balance, with African American individuals experiencing disproportionate exposure to EDCs through personal care products marketed to people of color. Under-resourced communities face compounding risks including aggressive late-stage diagnoses and healthcare access barriers that contribute to elevated breast cancer mortality. This proposal engages Acres Homes community members, including Active Living After Cancer (ALAC) participants, to assess knowledge and interest in environmental exposure education focused on personal care products, supporting development of the ALAC with Environmental Vitality (ALAC-ENV) intervention and examining associations between EDCs and excessive weight in breast cancer survivors and family members.

Specific Aim 1: Determine survivors' and family members' environmental exposure knowledge. Participants (n=30) will participate in focus group interviews to assess their interest and understanding of environmental exposures with an emphasis on personal care products.

Specific Aim 2: Determine the relationship between exposures to prevalent EDCs and BMI. A cross-sectional design to examine associations between BMI and measurements of non-persistent EDCs in urine and wristband samples of cancer survivors and family members.

Findings will inform an R-level grant to develop a randomized trial testing the efficacy of an adapted ALAC-ENV curriculum for dissemination and implementation in community settings, as well as foundation grant support for a cross-sectional study examining the association between body mass index, EDC exposure, and cancer in Acres Homes within the context of non-medical drivers of health.

Interventions

  • Other Surveys
    Electronic surveys will completed via REDCap.
  • Other Video
    Focus group sessions and community forums will be conducted via videoconference (Zoom)

Primary outcome measures

  • Outcome Measure [Time frame: Through study completion; an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Be a resident of Acres Home community
  • Be 18 years of age and older
  • Self-report a breast cancer diagnosis including subtypes OR be a family member of a survivor
  • If a breast cancer survivor: current or former participants of the ALAC program
  • Able to communicate in English

Exclusion criteria

  • Self-report metastatic breast cancer diagnosis
  • Unable to communicate in English
  • Not a breast cancer survivor or family member of a survivor

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-only

Study locations

United States · 1 center
  • The University of Texas M. D. Anderson Cancer Center — Houston

Identifiers

NCT: NCT07137468 · 2025-0698 · NCI-2025-06013

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗